Park Medi World targets 40% bed-capacity increase in FY27

Park Medi World Limited expects to commission 1,430 beds in FY27, 40% above its FY26 closing capacity of 3,610 beds, after adding 680 beds in the six months ended September 30, 2026 and reaching 4,290 beds at the reporting date.

How will Park Medi World add 1,430 beds in FY27?

Park Medi World plans to commission 1,430 beds in FY27 through acquisitions, greenfield commissioning, an expansion at an existing hospital and an operations and management arrangement. Management said the planned addition is equivalent to 40% of the 3,610 beds at FY26 close and would be its largest capacity addition in any fiscal.

The FY27 programme includes 680 beds added in the six months ended September 30, 2026. Park Medi World acquired a 330-bed hospital in Rudrapur and commissioned its 350-bed Panchkula hospital, its largest greenfield facility to date, lifting capacity by 19% in six months to 4,290 beds.

The stated 1,430-bed FY27 total implies 750 beds remain to be commissioned after September 30, 2026. Those identified projects are the 150-bed Mehar Hospital in Zirakpur, a 300-bed Kanpur hospital under an operations and management, or O&M, arrangement, the 200-bed Febris hospital in Narela, Delhi, and a 100-bed expansion at Palam Vihar in Gurugram.

Which projects are scheduled after September 2026?

Park Medi World expects the 150-bed Mehar Hospital in Zirakpur to be commissioned in the first week of December 2026. The announced acquisition has a valuation of Rs 107 crore, and Park Medi World said the facility would take its Tricity capacity to about 1,000 beds after the capacity expansion under way in Mohali is commissioned.

The 300-bed Kanpur facility is structured differently from the Zirakpur acquisition because Park Medi World will operate and manage it under a long-term O&M arrangement. The multi-super-speciality hospital is expected to be commissioned in Q4 FY27, while the release does not disclose an acquisition value, capital commitment or other financial terms for the arrangement.

Febris is a 200-bed multi-super-speciality hospital in Narela, while the Palam Vihar project adds 100 beds to an existing Gurugram facility. Park Medi World included both projects in its 1,430-bed FY27 plan but did not provide individual commissioning dates, leaving the timing of 300 beds unspecified in the November 13, 2026 release.

How has new capacity affected Park Medi World’s utilisation and profit?

Park Medi World reported lower occupancy as its bed base expanded. Q2 FY27 occupancy was 55.8%, versus 68.5% in Q2 FY26, a decline of 1,271 basis points as capacity increased 32% to 4,290 beds. H1 FY27 occupancy was 55.7%, down 1,247 basis points from 68.1% a year earlier.

Management said onboarding new facilities had an expected near-term effect on utilisation and profitability because they require time to ramp up. Patient volumes nevertheless grew: Q2 FY27 total patients increased 29% year on year to 290,000, including 31,000 inpatients and 259,000 outpatients, while H1 FY27 patients rose 23% to 539,000.

Earnings before interest, tax, depreciation and amortisation, or EBITDA, excluding other income fell in Q2 despite revenue growth. In H1 FY27, revenue from operations rose 22% to Rs 986.7 crore and EBITDA increased 5% to Rs 227.8 crore, but EBITDA margin declined to 23.1% from 26.9% and net profit slipped 1% to Rs 143.1 crore.

What funding information has Park Medi World disclosed?

Park Medi World reported total cash and cash equivalents, including other balances, of Rs 371.3 crore as of September 30, 2026, against term debt of Rs 177.9 crore. Fixed deposits accounted for Rs 295 crore of the reported cash and liquidity position.

Management cited the Rs 371.3 crore cash balance and Rs 177.9 crore term debt while saying it had the balance-sheet capacity to fund the FY27 rollout. However, the release does not disclose a total expansion budget, project-level construction costs, interest costs or financing mix for the planned 1,430 beds.

The disclosed Rs 107 crore Mehar Hospital valuation is the only stated transaction value among the post-September projects. This means the reported liquidity can be considered alongside the 1,430-bed plan, but the document does not establish the aggregate cost of executing acquisitions, greenfield commissioning, expansion and the Kanpur O&M arrangement.

Conclusion

Park Medi World has moved from 3,610 beds at FY26 close to 4,290 beds by September 30, 2026 through the 330-bed Rudrapur acquisition and 350-bed Panchkula commissioning. Its FY27 plan would add a further 750 beds, while the reported decline in occupancy to 55.7% in H1 FY27 and EBITDA margin to 23.1% shows the near-term operating effect management attributes to ramping new facilities.

The next disclosed milestones are the expected first-week-of-December 2026 commissioning of the 150-bed Mehar Hospital and the expected Q4 FY27 opening of the 300-bed Kanpur facility. Park Medi World has not disclosed dates for the 200-bed Febris hospital or 100-bed Palam Vihar expansion, and management has identified integration, utilisation and margins as priorities as the new capacity is added.